Ketorolac Tromethamine Injection, Solution
Product Images NDC 72572-355

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 72572-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Fig1)

Chemical structure diagram of Ketorolac Tromethamine showing its molecular composition, including a benzoyl cyclized ring and tromethamine moiety represented by hydroxymethyl groups attached to an amino group.*

FDA Label Image

Label (Ketorolac 01)

Label for Ketorolac Tromethamine Injection, USP 15 mg/mL. It is a 1 mL single dose vial for intravenous or intramuscular use. The label shows distribution by Civica, Inc., Lehi, Utah, and manufacturing by Caplin Steriles Limited, India, for Baxter Healthcare Corporation. Includes NDC 72572-354-01 and batch details.*

FDA Label Image

Carton (Ketorolac 02)

Label for Ketorolac Tromethamine Injection, USP 15 mg/mL, solution for injection supplied in 10 single-dose 1 mL vials. Indicated for intravenous or intramuscular use. The label states the product is sterile and includes storage conditions, manufacturer information, and a barcode. The labeler is Civica, Inc.*

FDA Label Image

Label (Ketorolac 03)

Label for Ketorolac Tromethamine Injection USP, 30 mg/mL strength, in a 1 mL single-dose vial. The injectable solution is indicated for intravenous or intramuscular use. Distributed by Civica, Inc., Lehi, Utah, and manufactured for Baxter Healthcare Corporation by Caplin Steriles Limited, India. The label includes NDC 72572-355-01 and a barcode.*

FDA Label Image

Carton (Ketorolac 04)

Label for Ketorolac Tromethamine Injection, USP, 30 mg/mL solution for injection by Civica, Inc. The product is intended for intravenous or intramuscular use and comes in a package of 25 single-dose 1 mL vials. The label includes active ingredient concentration, usage instructions, storage conditions, and manufacturing details for Baxter Healthcare Corporation in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.